Eye-Drop and Lubricants Market Overview
The large number of people suffering from eye problems across the world. Eye drops and lubricants are highly effective and less painful so they are mostly used in the treatment of eye problems. Globally, huge growth in eye disorders among the people such as dry eye, redness, refractive errors, glaucoma, soreness, conjunctivitis, itching, CMV retinitis, diabetic macular edema, and age-related macular degeneration. Thus, eye drops and lubricants have a huge demand for the treatment of these problems. It creates a positive outlook for the market.
According to World Health Organization, nearly 2.2 billion people have a near or distance vision impairment. With the same source, based on 2020 data, 137 million people live in trachoma endemic areas and are at risk of trachoma blindness. Hence it rises the number of eye surgeries that require eye drops and lubricants. Additionally, government initiatives such as the National Programme for Control of Blindness (NPCB) provide high-quality comprehensive Eye Care across the country. All these aspects positively affecting the Eye-Drop and Lubricants Market.
On the other hand, side effects related to ophthalmic eye drops and lubricants are expected to detain the growth of the market. However, rising investment by producers in the emerging countries. Also, moral initiatives to reduce the burden of glaucoma globally are expected to provide lucrative opportunities for market growth.
Eye-Drop and Lubricants Market Segment Overview
Based on type, the artificial tears segment holds the major share of the global eye-drop and lubricants market. This is due to the rising incidence of dry eye disorder globally. In addition, the hormones segment shows remarkable growth in the market. This is because of increasing dry eye problems in postmenopausal women. According to the application, the eye diseases segment is the fastest-growing segment in the market. This is due to the rising geriatric population across the world and the high incidence rate of eye problems.
Eye-Drop and Lubricants Market Regional Overview
North America commanded a major share of the global eye-drop and lubricants market. Some dynamic factors such as growing investments in the healthcare sector by manufacturers and the high growth rate of ophthalmic disorders in the region. All these contribute towards the market’s growth. Moreover, the market in the Asia Pacific is expected to show noteworthy growth due to rapid development in health care infrastructure and favorable government initiatives for the healthcare sector.
Eye-Drop and Lubricants Market Competitor overview
· In October 2019,- Allergan plc a leading global pharmaceutical company with a more than 70-year heritage in eye care, announced the launch of three new over-the-counter (OTC) REFRESH® RELIEVA™ products: such as REFRESH® RELIEVA™, REFRESH® RELIEVA™ PF (preservative-free) multidose, and REFRESH® RELIEVA™ FOR CONTACTS. This new line of artificial tear formulations available in preserved, preservative-free multidose, and a formula designed for contact lens wearers, are specially formulated to relieve discomfort due to eye dryness and to prevent further irritation.
· February 2019, Bausch + Lomb, a leading global eye health company and a wholly-owned subsidiary of Bausch Health Companies Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38%, a new gel formulation for the treatment of postoperative inflammation and pain following ocular surgery.
Eye-Drop and Lubricants Market, Key Players
· Novartis International AG (Alcon Inc.)
· Akorn Consumer Health (TheraTears)
· Allergan plc
· ROHTO Pharmaceutical Co., Ltd.
· Johnson & Johnson, Pfizer, Inc.
· Similasan Corporation USA
· Sager Pharma Kft.
· Prestige Consumer Healthcare, Inc.
· Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
· Bayer
· Bausch Lomb
· Abbott Laboratories
· Aerie Pharmaceuticals
Eye-Drop and Lubricants Market Segmentation
Eye-Drop and Lubricants Market, By Type
· Antibiotics
· Hormone
· Artificial tears
· Others
Eye-Drop and Lubricants Market, By Application
· Eye Disease
· Eye Care
· Others
Eye-Drop and Lubricants market, By Region
The large number of people suffering from eye problems across the world. Eye drops and lubricants are highly effective and less painful so they are mostly used in the treatment of eye problems. Globally, huge growth in eye disorders among the people such as dry eye, redness, refractive errors, glaucoma, soreness, conjunctivitis, itching, CMV retinitis, diabetic macular edema, and age-related macular degeneration. Thus, eye drops and lubricants have a huge demand for the treatment of these problems. It creates a positive outlook for the market.
According to World Health Organization, nearly 2.2 billion people have a near or distance vision impairment. With the same source, based on 2020 data, 137 million people live in trachoma endemic areas and are at risk of trachoma blindness. Hence it rises the number of eye surgeries that require eye drops and lubricants. Additionally, government initiatives such as the National Programme for Control of Blindness (NPCB) provide high-quality comprehensive Eye Care across the country. All these aspects positively affecting the Eye-Drop and Lubricants Market.
On the other hand, side effects related to ophthalmic eye drops and lubricants are expected to detain the growth of the market. However, rising investment by producers in the emerging countries. Also, moral initiatives to reduce the burden of glaucoma globally are expected to provide lucrative opportunities for market growth.
Eye-Drop and Lubricants Market Segment Overview
Based on type, the artificial tears segment holds the major share of the global eye-drop and lubricants market. This is due to the rising incidence of dry eye disorder globally. In addition, the hormones segment shows remarkable growth in the market. This is because of increasing dry eye problems in postmenopausal women. According to the application, the eye diseases segment is the fastest-growing segment in the market. This is due to the rising geriatric population across the world and the high incidence rate of eye problems.
Eye-Drop and Lubricants Market Regional Overview
North America commanded a major share of the global eye-drop and lubricants market. Some dynamic factors such as growing investments in the healthcare sector by manufacturers and the high growth rate of ophthalmic disorders in the region. All these contribute towards the market’s growth. Moreover, the market in the Asia Pacific is expected to show noteworthy growth due to rapid development in health care infrastructure and favorable government initiatives for the healthcare sector.
Eye-Drop and Lubricants Market Competitor overview
· In October 2019,- Allergan plc a leading global pharmaceutical company with a more than 70-year heritage in eye care, announced the launch of three new over-the-counter (OTC) REFRESH® RELIEVA™ products: such as REFRESH® RELIEVA™, REFRESH® RELIEVA™ PF (preservative-free) multidose, and REFRESH® RELIEVA™ FOR CONTACTS. This new line of artificial tear formulations available in preserved, preservative-free multidose, and a formula designed for contact lens wearers, are specially formulated to relieve discomfort due to eye dryness and to prevent further irritation.
· February 2019, Bausch + Lomb, a leading global eye health company and a wholly-owned subsidiary of Bausch Health Companies Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38%, a new gel formulation for the treatment of postoperative inflammation and pain following ocular surgery.
Eye-Drop and Lubricants Market, Key Players
· Novartis International AG (Alcon Inc.)
· Akorn Consumer Health (TheraTears)
· Allergan plc
· ROHTO Pharmaceutical Co., Ltd.
· Johnson & Johnson, Pfizer, Inc.
· Similasan Corporation USA
· Sager Pharma Kft.
· Prestige Consumer Healthcare, Inc.
· Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
· Bayer
· Bausch Lomb
· Abbott Laboratories
· Aerie Pharmaceuticals
Eye-Drop and Lubricants Market Segmentation
Eye-Drop and Lubricants Market, By Type
· Antibiotics
· Hormone
· Artificial tears
· Others
Eye-Drop and Lubricants Market, By Application
· Eye Disease
· Eye Care
· Others
Eye-Drop and Lubricants market, By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Eye-Drop and Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Antibiotics
- 5.2.2. Hormone
- 5.2.3. Artificial tears
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Eye Disease
- 5.3.2. Eye Care
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Latin America
- 5.4.3. Europe
- 5.4.4. Asia Pacific
- 5.4.5. Middle East and Africa
6. North America Eye-Drop and Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Antibiotics
- 6.2.2. Hormone
- 6.2.3. Artificial tears
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Eye Disease
- 6.3.2. Eye Care
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Latin America Eye-Drop and Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Antibiotics
- 7.2.2. Hormone
- 7.2.3. Artificial tears
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Eye Disease
- 7.3.2. Eye Care
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. Brazil
- 7.4.2. Mexico
- 7.4.3. Rest of Latin America
8. Europe Eye-Drop and Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Antibiotics
- 8.2.2. Hormone
- 8.2.3. Artificial tears
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Eye Disease
- 8.3.2. Eye Care
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. UK
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Russia
- 8.4.7. Rest of Europe
9. Asia Pacific Eye-Drop and Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Antibiotics
- 9.2.2. Hormone
- 9.2.3. Artificial tears
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Eye Disease
- 9.3.2. Eye Care
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. China
- 9.4.2. India
- 9.4.3. Japan
- 9.4.4. Australia
- 9.4.5. South East Asia
- 9.4.6. Rest of Asia Pacific
10. Middle East & Africa Eye-Drop and Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Type
- 10.2.1. Antibiotics
- 10.2.2. Hormone
- 10.2.3. Artificial tears
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast – By Application
- 10.3.1. Eye Disease
- 10.3.2. Eye Care
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast – By Country
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Novartis International AG (Alcon Inc.)
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Akorn Consumer Health (TheraTears)
- 11.6. Allergan plc
- 11.7. ROHTO Pharmaceutical Co., Ltd.
- 11.8. Johnson & Johnson, Pfizer, Inc.
- 11.9. Similasan Corporation USA
- 11.10. Sager Pharma Kft.
- 11.11. Prestige Consumer Healthcare, Inc.
- 11.12. Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
- 11.13. Bayer
- 11.14. Bausch Lomb
- 11.15. Abbott Laboratories